Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$78,329 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Jun 30, 2026CallValue
$774,891
CallShares
11,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in NKTR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $774,891 | 11,100 | Call | Defined | 2026-08-14 | |
| 2025-03-31 | $78,329 | 115,190 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $162,929 | 175,193 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $62,054 | 47,734 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $429,846 | 346,650 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,370,559 | 2,548,990 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,295,352 | 4,098,844 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,673,814 | 6,123,024 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,308,346 | 9,152,321 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,311,162 | 3,301,661 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,549,089 | 1,127,916 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,172,547 | 678,921 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,093,632 | 550,956 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,458,320 | 641,618 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,231,517 | 387,233 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,460,565 | 415,399 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,592,186 | 325,885 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,298,220 | 414,911 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $297,500 | 17,500 | Put | Defined | 2021-02-16 | |
| 2020-12-31 | $16,779,238 | 987,014 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,968,869 | 540,619 | Shares | Defined | 2020-11-16 | |
| 2020-09-30 | $290,325 | 17,500 | Put | Defined | 2020-11-16 | |
| 2020-06-30 | $12,117,937 | 523,227 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $405,300 | 17,500 | Put | Defined | 2020-08-14 | |
| 2020-03-31 | $279,120 | 15,637 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $312,375 | 17,500 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||